Manufacturing

Kite to bolster cell therapy manufacturing capabilities with new viral vector facility

Kite, a Gilead Company (Nasdaq: GILD), today announced plans for a new 67,000-square-foot facility in Oceanside, California, dedicated to the development and manufacturing of viral vectors, a critical starting material in the production of cell therapies.

Nexus Pharmaceuticals to build sterile injectable production facility in Wisconsin

US-based healthcare firm Nexus Pharmaceuticals is set to construct a new sterile injectable manufacturing facility in Wisconsin, US.

BMS plans to sell Celgene’s psoriasis drug Otezla

Bristol-Myers Squibb (BMS) is planning to divest Celgene’s psoriasis drug Otezla (apremilast), in a bid to expedite the process of merger with Celgene.

Gamida Cell, Lonza establish commercial manufacturing agreement for omidubicel

Gamida Cell and Lonza announced that the companies have entered into a strategic manufacturing agreement.

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

WuXi Biologics, a global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has entered into a strategic partnership letter of intent (LOI) with a global vaccine leader, pursuant to which WuXi Vaccines will build a dedicated facility and supply a commercial product for the global market.

Catalent wraps up $1.2bn acquisition of gene therapy CDMO Paragon

Catalent has wrapped up its $1.2bn acquisition of Maryland-based gene therapy contract development and manufacturing organisation (CDMO) Paragon Bioservices.

Thermo Fisher Scientific to acquire manufacturing site in Cork, Ireland, from GSK

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline plc (NYSE: GSK) for approximately €90 million in cash.

Pfizer opens new biologics clinical manufacturing facility in Massachusetts

Pfizer has announced the opening of a new 175,000 square-foot manufacturing facility in Andover, Massachusetts.

Kite announces plans for new state-of-the-art facility to expand cell therapy production capabilities

Kite, a Gilead Company (Nasdaq: GILD), today announced plans for a new facility in Frederick County, Maryland, which will produce innovative cell therapies for people with cancer.